Wikidata

(Q61933775)

English

To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes

clinical trial

In more languages

Statements

title
A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Compare the Effects of 12 Weeks Treatment With Vildagliptin 50 mg Bid to Voglibose 0.2 mg Tid in Patients With Type 2 Diabetes (English)
0 references
sponsor
Novartis
0 references
country
Japan
0 references
start time
August 2006
0 references
number of participants
370
0 references
research intervention
vildagliptin
0 references
voglibose
0 references
research site
Novartis
0 references
minimum age
20 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61933775&oldid=2105537210"